Literature DB >> 8160875

Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans.

D Randin1, P Vollenweider, L Tappy, E Jéquier, P Nicod, U Scherrer.   

Abstract

Euglycemic hyperinsulinemia stimulates both sympathetic nerve activity and blood flow to skeletal muscle, but the mechanism is unknown. Possible mechanisms that may stimulate muscle blood flow include neural, humoral, or metabolic effects of insulin. To determine whether such insulin-induced vasodilation is modulated by stimulation of adrenergic or cholinergic mechanisms, we obtained, in eight healthy lean subjects, plethysmographic measurements of calf blood flow during 3 h of hyperinsulinemic (1 mU.kg-1.min-1) euglycemic clamp performed alone or during concomitant beta-adrenergic (propranolol infusion), cholinergic (atropine infusion), or alpha-adrenergic (prazosin administration) blockade. Euglycemic hyperinsulinemia alone increased calf blood flow by 38 +/- 10% (means +/- SE) and decreased vascular resistance by 27 +/- 4% (P < 0.01). The principal new observation is that these insulin-induced vasodilatory responses were not attenuated by concomitant propranolol or atropine infusion, nor were they potentiated by prazosin administration. In conclusion, these findings provide evidence that during euglycemic hyperinsulinemia in lean healthy humans stimulation of muscle blood flow is not mediated primarily by beta-adrenergic or cholinergic mechanisms. Furthermore, alpha-adrenergic mechanisms do not markedly limit insulin-induced stimulation of muscle blood flow.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160875     DOI: 10.1152/ajpregu.1994.266.3.R809

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Body fat and sympathetic nerve activity.

Authors:  U Scherrer; R Owlya; M Lepori
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

2.  Sympathetically mediated increases in cardiac output, not restraint of peripheral vasodilation, contribute to blood pressure maintenance during hyperinsulinemia.

Authors:  Jacqueline K Limberg; James A Smith; Rogerio N Soares; Jennifer L Harper; Keeley N Houghton; Dain W Jacob; Michael T Mozer; Zachary I Grunewald; Blair D Johnson; Timothy B Curry; Tracy Baynard; Camila Manrique-Acevedo; Jaume Padilla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

3.  Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects.

Authors:  M Trovati; P Massucco; L Mattiello; F Cavalot; E M Mularoni; A W Hahn; G Anfossi
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 4.  Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia-Implications for Obesity and Insulin Resistance.

Authors:  Jacqueline K Limberg; Rogerio N Soares; Jaume Padilla
Journal:  Curr Diab Rep       Date:  2022-03-05       Impact factor: 4.810

5.  GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans.

Authors:  Sharmila C Subaran; Matthew A Sauder; Weidong Chai; Linda A Jahn; Dale E Fowler; Kevin W Aylor; Ananda Basu; Zhenqi Liu
Journal:  Clin Sci (Lond)       Date:  2014-08       Impact factor: 6.124

6.  Nitric oxide release accounts for insulin's vascular effects in humans.

Authors:  U Scherrer; D Randin; P Vollenweider; L Vollenweider; P Nicod
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  Effects of insulin on vascular responses to spinal cord stimulation and vasoactive agents in pithed rats.

Authors:  Shingo Takatori; Masako Mizote; Yoshito Zamami; Yuji Kurosaki; Hiromu Kawasaki
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

8.  Sugar-sweetened soft drink consumption acutely decreases spontaneous baroreflex sensitivity and heart rate variability.

Authors:  Christopher L Chapman; Emma L Reed; Morgan L Worley; Leonard D Pietrafesa; Paul J Kueck; Adam C Bloomfield; Zachary J Schlader; Blair D Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-02-03       Impact factor: 3.619

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.